{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:12:37Z","timestamp":1793293957475,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["130061"],"award-info":[{"award-number":["130061"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["116027"],"award-info":[{"award-number":["116027"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017439","name":"Liaoning Province Government","doi-asserted-by":"publisher","award":["2019JH8\/10300027"],"award-info":[{"award-number":["2019JH8\/10300027"]}],"id":[{"id":"10.13039\/100017439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017439","name":"Liaoning Province Government","doi-asserted-by":"publisher","award":["2023JH6\/100100019"],"award-info":[{"award-number":["2023JH6\/100100019"]}],"id":[{"id":"10.13039\/100017439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017439","name":"Liaoning Province Government","doi-asserted-by":"publisher","award":["XLYC1902036"],"award-info":[{"award-number":["XLYC1902036"]}],"id":[{"id":"10.13039\/100017439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017439","name":"Liaoning Province Government","doi-asserted-by":"publisher","award":["LZ2020003"],"award-info":[{"award-number":["LZ2020003"]}],"id":[{"id":"10.13039\/100017439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009965","name":"Dalian Science and Technology Bureau","doi-asserted-by":"publisher","award":["2019J12SN56"],"award-info":[{"award-number":["2019J12SN56"]}],"id":[{"id":"10.13039\/501100009965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.isci.2024.109851","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T05:25:54Z","timestamp":1714454754000},"page":"109851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-\u03baB\/CD44 pathway inhibition"],"prefix":"10.1016","volume":"27","author":[{"given":"Xijia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhu","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Arian","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4109-2602","authenticated-orcid":false,"given":"Jinsong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109851_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2024.109851_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109851_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12943-018-0801-5","article-title":"Advances in studies of tyrosine kinase inhibitors and their acquired resistance","volume":"17","author":"Jiao","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2024.109851_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109851_bib5","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.109851_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-019-0729-2","article-title":"Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges","volume":"12","author":"Soverini","year":"2019","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.isci.2024.109851_bib7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/leu.2017.253","article-title":"Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants","volume":"31","author":"Hehlmann","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109851_bib8","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/leu.2012.104","article-title":"Standardized definitions of molecular response in chronic myeloid leukemia","volume":"26","author":"Cross","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109851_bib9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2024.109851_bib10","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1182\/bloodadvances.2020003235","article-title":"Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel","volume":"5","author":"Pavlovsky","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2024.109851_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and Resistance to BCR-ABL1-Targeted Therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109851_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000468","article-title":"Chronic Myeloid Leukemia in 2020","volume":"4","author":"Hehlmann","year":"2020","journal-title":"Hemasphere"},{"key":"10.1016\/j.isci.2024.109851_bib13","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1200\/JCO.2008.18.6999","article-title":"Significance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic response","volume":"27","author":"Kantarjian","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109851_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.109851_bib15","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.3390\/cancers13225822","article-title":"Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia","volume":"13","author":"Ito","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2024.109851_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2018.212365","article-title":"The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL\/TAL1 - CD44 axis","volume":"105","author":"Godavarthy","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2024.109851_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.2020006343","article-title":"CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues","volume":"138","author":"Yu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109851_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00018-015-2108-7","article-title":"Survival regulation of leukemia stem cells","volume":"73","author":"Hu","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2024.109851_bib19","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109851_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47248-8","article-title":"Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines","volume":"9","author":"Lompardia","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109851_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41556-018-0204-2","article-title":"Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria","volume":"20","author":"Wang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2024.109851_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2018.07.013","article-title":"The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK\/STAT Pathway in Advanced Chronic Myeloid Leukemia","volume":"34","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2024.109851_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopha.2018.05.047","article-title":"Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21","volume":"104","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2024.109851_bib24","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1093\/nar\/gku549","article-title":"A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies","volume":"42","author":"Sun","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109851_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtn.2018.04.013","article-title":"Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition","volume":"12","author":"Pian","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2024.109851_bib26","first-page":"543","article-title":"Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-kappaB signaling pathway","volume":"37","author":"Guo","year":"2022","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.isci.2024.109851_bib27","doi-asserted-by":"crossref","first-page":"14929","DOI":"10.1007\/s13277-016-5380-8","article-title":"Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer","volume":"37","author":"Lian","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2024.109851_bib28","first-page":"543","article-title":"Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-\u03baB signaling pathway","volume":"37","author":"Guo","year":"2022","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.isci.2024.109851_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41419-018-0900-7","article-title":"Novel AF1q\/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2024.109851_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bib\/bbv031","article-title":"Revealing protein-lncRNA interaction","volume":"17","author":"Ferre","year":"2016","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.isci.2024.109851_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106966","article-title":"NF-kappaB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109851_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-021-01866-1","article-title":"ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-kB\/CD44 pathway in urinary bladder carcinoma","volume":"40","author":"Zhang","year":"2021","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109851_bib33","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.ajpath.2015.04.004","article-title":"The homeoprotein DLX4 stimulates NF-kappaB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer","volume":"185","author":"Haria","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2024.109851_bib34","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/leu.2017.87","article-title":"Combined inhibition of beta-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in\u00a0vitro and in\u00a0vivo","volume":"31","author":"Zhou","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109851_bib35","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.109851_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2018-03-785915","article-title":"How I treat MDS after hypomethylating agent failure","volume":"133","author":"Santini","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109851_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cncr.22470","article-title":"Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia","volume":"109","author":"Oki","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2024.109851_bib38","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3892\/ol.2017.6318","article-title":"Role and mechanism of decitabine combined with tyrosine kinase inhibitors in advanced chronic myeloid leukemia cells","volume":"14","author":"Jiang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2024.109851_bib39","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Na\u00efve Chronic Myeloid Leukemia Patients Trial","volume":"34","author":"Cortes","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109851_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia","volume":"25","author":"Bixby","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109851_bib41","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1200\/JCO.2008.19.4076","article-title":"Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance","volume":"27","author":"Zhang","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109851_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/imr.12234","article-title":"Do we need more drugs for chronic myeloid leukemia?","volume":"263","author":"Holyoake","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2024.109851_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41375-018-0192-z","article-title":"Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia","volume":"33","author":"Vicente-Duenas","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109851_bib44","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020004834","article-title":"An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia","volume":"135","author":"Ko","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109851_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109851_bib46","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"Lovly","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109851_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3324\/haematol.2015.139337","article-title":"Chronic myeloid leukemia: reminiscences and dreams","volume":"101","author":"Mughal","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2024.109851_bib48","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1182\/blood-2002-12-3659","article-title":"Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib","volume":"101","author":"Corbin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109851_bib49","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109851_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised Estimates for the Number of Human and Bacteria Cells in the Body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.isci.2024.109851_bib51","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","article-title":"Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition","volume":"6","author":"Scott","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2024.109851_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drup.2009.06.001","article-title":"Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches","volume":"12","author":"Konopleva","year":"2009","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.isci.2024.109851_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12032-021-01524-8","article-title":"Cancer stem cell characteristics and their potential as therapeutic targets","volume":"38","author":"Lim","year":"2021","journal-title":"Med. Oncol."},{"key":"10.1016\/j.isci.2024.109851_bib54","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41375-020-0866-1","article-title":"Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia","volume":"34","author":"Kumar","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109851_bib55","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","article-title":"A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation","volume":"12","author":"Reuther","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2024.109851_bib56","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/onc.2011.156","article-title":"NF-kappaB suppresses ROS levels in BCR-ABL(+) cells to prevent activation of JNK and cell death","volume":"30","author":"Stein","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2024.109851_bib57","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1158\/1078-0432.CCR-17-0235","article-title":"Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia","volume":"23","author":"Shen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109851_bib58","article-title":"Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2024.109851_bib59","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11596-020-2266-1","article-title":"AICAR and Decitabine Enhance the Sensitivity of K562 Cells to Imatinib by Promoting Mitochondrial Activity","volume":"40","author":"Zhu","year":"2020","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.isci.2024.109851_bib60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/gtmb.2017.0281","article-title":"Low Expression of Long Noncoding RNA IRAIN Is Associated with Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients","volume":"22","author":"Pashaiefar","year":"2018","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.isci.2024.109851_bib61","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biom11121850","article-title":"CD44: A Multifunctional Mediator of Cancer Progression","volume":"11","author":"Hassn Mesrati","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2024.109851_bib62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/bc9004365","article-title":"Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment","volume":"21","author":"Mendon\u00e7a","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.isci.2024.109851_bib63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.stem.2020.04.005","article-title":"Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors","volume":"27","author":"Rothe","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2024.109851_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.109851_bib65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2024.109851_bib66","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2024.109851_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq1316","article-title":"Efficient detection of RNA-protein interactions using tethered RNAs","volume":"39","author":"Iioka","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109851_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6380-5_7","article-title":"RIP: RNA Immunoprecipitation","volume":"1480","author":"Gagliardi","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2024.109851_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-020-01253-y","article-title":"Circular RNA CDR1as disrupts the p53\/MDM2 complex to inhibit Gliomagenesis","volume":"19","author":"Lou","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224010733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224010733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:33:10Z","timestamp":1782538390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224010733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2589004224010733"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109851","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-\u03baB\/CD44 pathway inhibition","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109851"}}